Page 93 - AN-4-4
P. 93

Advanced Neurology                                                   Cytokine response to EV therapy in SCI



            Appendix

                            IL‑2  491.42  236.89  VEGF  58.39  37.16  IL‑2*  955.11  368.14  VEGF  91.38  41.92  IL‑2  783.93  368.62  VEGF  76.27  29.55  IL‑2  510.74  322.05  VEGF  67.54  57.41
                      Table A1. Multiplex analysis of cytokine levels (pg/mL) in spinal cord homogenates (Th8) from control (SCI and SCI FM) and experimental (SCI FM+EVs5 and SCI


                            IL‑1b  88.45  22.71  TNF‑α  382.69  72.71  IL‑1b**  133.09  30.48  TNF‑α  443.78  66.61  IL‑1b  107.86  44.21  TNF‑α  401.07  155.25  IL‑1b  84.05  32.49  TNF‑α  363.19  136.28




                            IL‑1a  127.2  45.73  RANTES #  65.4  14.97  IL‑1a  115.34  18.01  RANTES  136.11  41.6  IL‑1a  92.7  44.66  RANTES  266.24  187.73  IL‑1a  67.43  49.62  RANTES  83.79  42.15




                            IL‑18  968.96  154.43  MIP‑3α  10.02  7.21  IL‑18*  1229.89  214.61  MIP‑3α*  23.32  9.43  IL‑18  1012.03  387.98  MIP‑3α  14.91  6.51  IL‑18  1085.37  193.01  MIP‑3α  10.27  8.65




                            IL‑13  83.6  67.25  MIP‑1α  76.32  28.41  IL‑13  173.94  67.58  MIP‑1α  65.68  31.63  IL‑13  112.00  59.22  MIP‑1α  70.47  33.13  IL‑13  89.95  80.9  MIP‑1α  58.95  34.64




                            IL‑12p70  67.52  45.12  MCP‑1  417.28  145.71  IL‑12p70  122.72  43.9  MCP‑1  425.51  160.03  IL‑12p70  96.98  56.27  MCP‑1  497.4  51.2  IL‑12p70  61.94  55.11  MCP‑1  413.48  73.81




                            IL‑10  160.71  147.75  M‑CSF  40.22  21.02  IL‑10**  383.05  155.00  M‑CSF*  68.17  19.09  IL‑10  267.65  129.06  M‑CSF  44.9  21.6  IL‑10  156.77  168.55  M‑CSF  43.21  33.27




                            IFN‑γ  198.42  167.21  IL‑17A  89.39  33.37  IFN‑γ*  454.60  182.50  IL‑17A**  123.77  20.43  IFN‑γ  299.97  161.49  IL‑17A  105.64  37.57  IFN‑γ  204.49  200.25  IL‑17A  75.34  47.59 Abbreviations: CSF: colony-stimulating factor; G-CSF: Granulocyte CSF; GM-CSF: Granulocyte–macrophage CSF; GRO/KC: Growth-related oncogene/keratinocyte-derived chemokine;   IFN: Interferon; IL: Interleukin; M-CSF: macrophage CSF; MCP: Monocyte chemoattractant prot



                            GRO/KC  46.15  17.68  IL‑7  20.02  16.00  GRO/KC  41.97  11.67  IL‑7*  48.88  18.91  GRO/KC  39.15  14.59  IL‑7  33.44  14.30  GRO/KC  33.75  11.93  IL‑7  26.89  14.42 Notes: *p<0.05 compared to SCI group; **p<0.05 compared to SCI and SCI FM+EVs10 groups;  # p<0.05 compared to SCI FM and SCI FM+EVs5 groups.




                            GM‑CSF  36.65  18.20  IL‑6  209.64  207.07  GM‑CSF*  60.38  15.97  IL‑6*  504.43  214.77  GM‑CSF  51.06  16.61  IL‑6  337.51  194.33  GM‑CSF  38.09  26.77  IL‑6  214.9  215.75





                                    IL‑5  76.15  41.12  IL‑5**  142.57  44.97  IL‑5  115.92  41.8  IL‑5  74.14  48.99
                            G‑SCF  9.90  11.37  G‑CSF*  28.17  14.70  G‑SCF  15.73  8.8  G‑SCF  9.99  11.97

                                    IL‑4  29.54  26.89  IL‑4  68.09  31.18  IL‑4  44.95  20.64  IL‑4  27.98  28.69


                         FM+EVs10) groups  Mean value  Standard deviation  Mean value  Standard deviation  SCI FM  Mean value  Standard deviation  SCI FM  Mean value  Standard deviation  SCI FM+EVs5  Mean value  Standard deviation  SCI FM+EVs5  Mean value  Standard deviation  SCI FM+EVs10  Mean value  Standard deviation  SCI FM+EVs10  Mean value  Standard deviation  endothelial growth factor.






                            SCI

            Volume 4 Issue 4 (2025)   SCI                   87                           doi: 10.36922/AN025110022
   88   89   90   91   92   93   94   95   96   97   98